Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-021660
Filing Date
2025-08-13
Accepted
2025-08-13 16:49:54
Documents
1
Period of Report
2025-08-11

Document Format Files

Seq Description Document Type Size
1 form4-08132025_080851.html 4  
1 form4-08132025_080851.xml 4 5480
  Complete submission text file 0001415889-25-021660.txt   6950
Mailing Address 550 HAMILTON AVENUE, SUITE 100 PALO ALTO CA 94301
Business Address
Topper James N (Reporting) CIK: 0001341382 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41562 | Film No.: 251212476

Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Issuer) CIK: 0001936258 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)